CanadaBis Capital (CANB) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Feb, 2026Executive summary
Achieved record gross revenue of $9.6 million for Q1 F2025, a 7% increase year-over-year.
Net income reached $321,569, reversing a loss from the prior quarter.
Adjusted EBITDA was $675,892, reflecting operational profitability.
Launched multiple new products, including high-potency pre-rolls and innovative concentrate offerings.
Initiated first international shipments to Europe, expanding geographic reach.
Financial highlights
Gross revenue rose to $9.6 million from $9.0 million year-over-year.
Net revenue for Q1 F2025 was $5.1 million, down 11.74% year-over-year but up 31% sequentially from Q4 2024.
Gross profit for the quarter was $2.2 million.
Sold over 570,000 units, a 4% increase from the prior year.
Outlook and guidance
Management expects continued cost reductions through supplier negotiations and operational efficiencies throughout 2025.
Anticipates growth from new product launches and international expansion.
Plans to optimize capacity allocation to maintain mandated gross profit margins.
Latest events from CanadaBis Capital
- Q3 2024 delivered robust revenue, profit, and margin gains, fueled by innovation and efficiency.CANB
Q3 202425 Feb 2026 - FY2024 net income reached $600,285, driven by new products and operational efficiencies.CANB
Q4 202425 Feb 2026 - Q2 2025 gross revenue surged 29% to $9M, with adjusted EBITDA of $434K and net earnings of $96K.CANB
Q2 202525 Feb 2026 - Achieved positive adjusted EBITDA, improved margins, and strengthened liquidity despite market headwinds.CANB
Q3 202525 Feb 2026 - Gross profit and adjusted EBITDA fell despite stable revenue, with new strategies set for 2026 growth.CANB
Q4 202525 Feb 2026 - Positive cash flow and margin gains achieved despite revenue decline and market disruptions.CANB
Q1 202625 Feb 2026